-
Cerebrospinal fluid amyloid-beta as potential biomarker for cognitive functioning in multiple sclerosis
Van Dam, M., Willemse, E., Nauta, I., Huiskamp, M., Klein, M., Moraal, B., Geurts, J., Uitdehaag, B., Teunissen, C., De Jong, B. & Hulst, H., Dec 2020, In: MULTIPLE SCLEROSIS JOURNAL. 26, 3_SUPPL, p. 495-496Research output: Contribution to journal › Meeting Abstract › Academic
- All publications